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ABSTRACT.  
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Photothermal therapy (PTT) has been proved to be an efficient approach for cancer 
treatment. However, accurately monitoring the spatial distribution of photothermal 
transducing agents (PTAs) and mapping the real-time temperature change in tumor 
and peritumoral normal tissue remain a huge challenge. Here, we propose an 
innovative strategy to integrate T1 weighted imaging (T1WI) for precisely tracking 
PTAs with magnetic resonance temperature imaging (MRTI) for real-time monitoring 
temperature change in vivo during PTT. NaBiF4: Gd@PDA@PEG nanomaterials 
were synthesized with favorable T1-weighted performance to target tumor and 
localize PTAs. The extremely weak susceptibility (1.04*10-6 emu g-1 Oe-1) of NaBiF4: 
Gd@PDA@PEG interferes with the local phase marginally, which maintains the 
capability of MRTI to dynamically record real-time temperature change in tumor and 
peritumoral normal tissue. The time resolution is 19 seconds per frame, and the 
detection precision of temperature change is approximately as low as 0.1 K. The 
approach combining anatomic and functional MRI to achieve accurate temperature 
monitoring during multi-mode MRI guided PTT holds significant potential for the 
clinical application. 
 
Photothermal therapy (PTT) that employs photothermal transducing agents (PTAs) to 
convert absorbed light energy into heat for eradicating the tumor, is an effective 
method 1-9. Numerous approaches based on nanoPTAs have been developed to treat 
tumor during the past decades. Because nanoPTAs can effectively target tumor, and 
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the laser beam is further utilized to directly focus on tumor to improve the PTT 
accuracy10-19. However, the precise location of nanoPTAs in tumor and the accurate 
monitoring of real-time temperature in tumor and adjacent healthy tissue, are the main 
obstacles to acquire accurate PTT. Inevitably, when PTT is conducted, one side effect 
is the damage to peritumoral normal tissue caused by rapid heating, including 
disrupting cell components, changing membrane permeability, and even denaturing 
tissue structural proteins20-22. Consequently, it is essential for PTT optimization to 
evaluate the delivery efficiency and spatial distribution of nanoPTAs, as well as the 
remote mapping and accurate monitoring of local temperature (i.e., maximizing 
thermal ablation of the tumor and minimizing damage to the healthy tissue).  
Magnetic resonance imaging (MRI) has been widely employed in clinical 
noninvasive diagnosis and laboratory scientific research with high resolution and 
unlimited penetration depth in soft tissues 23-27. Besides the commonly utilized 
anatomic techniques of T1/T2 weighted MRI, many functional MRI modalities have 
been developed and applied. Particularly, when MRI with multi-modal contrast agents 
(CAs) is conducted, anatomic MRI is capable of assessing the delivery and spatial 
distribution of CAs, contributing to more detailed anatomic information. Furthermore, 
functional MRI is qualified for sensitively monitoring the microenvironment of 
tumor. Recently, our group developed several multi-modal MRI CAs, through the 
marriage between anatomic MRI and functional MRI, which achieved accurate 
localization of tumor and detection of the tumor microenvironment (pH, blood 
vessel)28-30. Otherwise, few studies have been reported on combining anatomic MRI 
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with functional MRI for real-time tumor temperature during PTT. Magnetic resonance 
temperature imaging (MRTI), through a proton resonance frequency (PRF) method, 
can real-time and accurately monitor the temperature change in the target area, which 
is based on the linear relationship between temperature and phase31-35. However, the 
strong susceptibility brought by T2-MRI CAs will disturb the local phase, and further 
inhibit the accuracy of monitoring temperature36-37. Therefore, it is a tough challenge 
that reasonable designing MRI CAs confirms the distribution and acquires accurate 
real-time temperature mapping during PTT on a single MRI machine.   
In this study, we proposed an effective strategy that integrated MRI (T1/MRTI) 
was applied to achieve the precise temperature monitoring during PTT on a single 
MR machine. Anatomic MRI (T1-MRI) was utilized to track nanoPTAs and capture 
detailed structural information in tumor. Meanwhile, functional MRI (MRTI) was 
conducted to accurately record the real-time temperature change in tumor and 
peritumoral normal tissue. As shown in Scheme 1, NaBiF4: Gd@PDA@PEG 
nanomaterials were constructed with outstanding photothermal conversion 
performance and T1-weighted capability. The distribution of nanoPTAs in tumor was 
recorded through T1-weighted MRI. More importantly, NaBiF4: Gd@PDA@PEG 
nanoparticles could further guarantee the accuracy of temperature mapping with 
intensely weak local phase susceptibility (1.04*10-6 emu g-1 Oe-1). Therefore, MRTI 
was performed on an 11.7 T ultra-high field magnetic resonance machine to record 
the real-time and accurate temperature change in tumor and peritumoral normal 
tissues during PTT. The time resolution was 19 seconds per frame, and the detection 
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accuracy of temperature change was approximately as low as 0.1 K. These results 
clarified that integrated MRI could be competent for guiding PTT, which was of great 
significance to further promote clinical PTT.  
Synthesis and characterization of NaBiF4: Gd@PDA@PEG  
NaBiF4: Gd nanoparticles were synthesized by a simple method (Figure S1 and 
Figure S2) 38. Polydopamine (PDA) was then coated onto NaBiF4: Gd nanoparticles 
to transform them into hydrophilic. PEG-NH2 molecules were further grafted onto 
PDA through a Schiff base reaction, which further improved the biocompatibility39. 
Evidently, transmission electron microscopy (TEM) demonstrated that NaBiF4: 
Gd@PDA@PEG nanoparticles were uniform and with a diameter around 120 nm 
(Figure 1A). And element mapping images confirmed the successful synthesis 
(Figure 1B-C). Furthermore, X-ray photoelectron spectroscopy (XPS) also showed 
that NaBiF4: Gd@PDA@PEG nanoparticles were successfully prepared (Figure 
1D-I). Dynamic light scattering (DLS) indicated the hydration size of NaBiF4: 
Gd@PDA@PEG was around 148.8 nm in water (Figure S3). Meanwhile, the results 
of X-ray diffraction (XRD) pattern also verified the successful synthesis of NaBiF4: 
Gd and NaBiF4: Gd@PDA@PEG nanoparticles. Gd3+ ions doping slightly changed 
the crystal form of NaBiF4. After coated with PDA and PEG, the resulting 
nanoparticles showed a little amorphous (Figure S4). Fourier transform infrared 
(FT-IR) spectra were performed to confirm the successful synthesis and modification 
of NaBiF4: Gd, NaBiF4: Gd@PDA and NaBiF4: Gd@PDA@PEG nanoparticles 
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(Figure S5). In addition, X-ray photoelectron spectroscopy (XPS) was conducted to 
characterize the compositions, which further exhibited the successful preparation of 
NaBiF4: Gd and NaBiF4: Gd@PDA@PEG nanoparticles (Figure S6). 
To evaluate the photothermal performance, PDA coating content was firstly 
investigated. Thermogravimetric analysis (TG) and differential scanning calorimeter 
(DSC) showed PDA coating content was about 26% accompanied by an exothermic 
reaction (Figure S7). From the results of UV-Visible-NIR absorption spectra (Figure 
S8A), NaBiF4: Gd@PDA@PEG had unique absorption feature in visible and near 
infrared (I) regions. Moreover, according to the equation of Lambert-Beer law 
(A=εLc), the extinction coefficient (ε) was calculated to be 5.08 L g-1 cm-1 at the 
808-nm wavelength (Figure S8B). As we all knew, polydopamine (PDA) had 
excellent photothermal converting performance, which could be adopted to kill 
tumor.40-43 As shown in Figure S9A-B, NaBiF4: Gd@PDA@PEG also exhibited 
favorable photothermal performance. Therefore, the photothermal treatment 
efficiency of NaBiF4: Gd@PDA@PEG was further studied on cells. From Figure 
S10A-C, the results firstly revealed that the nanoparticles could be well swallowed by 
cells. Even Bi concentration was as high as 800 ppm, the cell viability was still above 
85%, which meant NaBiF4: Gd@PDA@PEG had low cytotoxicity and excellent 
biocompatibility (Figure S11A). After irradiation, a number of cells died and the 
viability was dependent on concentration (Figure S11B). In order to further 
investigate the photothermal ability for killing tumor cells, calcein-AM and propidium 
iodide (PI) were utilized to distinguish live and dead cells. The final results indicated 
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most cells were overheated to death (Figure S12A-C), which also demonstrated the 
outstanding photothermal ability for tumor therapy. 
MRI performance and susceptibility in aqueous solution 
Doping Gd3+ ions brought favorable T1 weight-MRI performance. As shown in 
Figure 2A-B, T1 weighted-MRI performance of NaBiF4: Gd@PDA@PEG 
nanoparticles showed a concentration dependent tendency. It was obvious that 
longitudinal relaxation time decreased gradually with the increase of Gd in 
T1-mapping images. The longitudinal relaxation rate was ultimately calculated as 1.2 
mM-1 s-1, which indicated NaBiF4: Gd@PDA@PEG had excellent T1 weight-MRI 
performance. MRTI, based on the proton resonance frequency (PRF) method, can 
real-time and accurately monitor temperature change, depending on the relationship 
between temperature and phase. However, the local phase was vulnerable to strong 
susceptibility. Accordingly, the magnetism of NaBiF4: Gd@PDA@PEG was 
continued to be investigated. From the hysteresis loop, the magnetic susceptibility 
was calculated to be 1.04*10-6 emu g-1 Oe-1, which demonstrated NaBiF4: 
Gd@PDA@PEG had little magnetism and little effect on local phase (Figure 2C). 
Furthermore, the phase change along with temperature was further evaluated in agar. 
Through linear fitting between MR phase and temperature, the slope was about -0.1 
radian/K (Figure 2D). The relationship between phase and temperature unchanged by 
various Gd concentrations, which illustrated the nanomaterials were no interference 
with local phase and temperature accuracy. In contrast, we also tested the phase 
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change along with temperature in agar with Fe3O4 (Fe, 30 ppm) (Figure S13). As 
expected, iron had a great influence on local phase, causing sharp phase fluctuations 
during the test, which demonstrated that iron-based nanomaterials (including Fe3O4) 
were not suitable for sensitive and accurate temperature measurement through phase 
change. In conclusion, NaBiF4: Gd@PDA@PEG nanoparticles had promising 
potential for T1&MRTI dual-modality MRI guided PTT. 
T1&MRTI performance in vivo  
Subsequently, T1&MRTI dual-modality MRI was conducted for PTT in vivo. After 
NaBiF4: Gd@PDA@PEG nanoparticles were intratumorally injected into mice 
(Figure 3A-B), the region of tumor was immediately lit up. From the pseudo-color 
images, the distribution of nanoPTAs could be observed more clearly (Figure 3C-D). 
The results indicated that the nanomaterials had shortened T1, which could be utilized 
to localize tumor and track PTAs. Then, the T1 value in the region of interest (ROI) 
was measured in pre and post. Obviously, after injection of the nanomaterials, the T1 
signal value increased significantly from 11.58 to 20.27 (Figure S14), which further 
demonstrated the nanomaterials had outstanding T1-weighted MRI performance.  
After locating the nanomaterials, the irradiation experiments were carried out. 
Simultaneously, MRTI was utilized to record the real-time temperature change. As 
shown in Figure 3E-F, the temperature mapping and real-time variation in tumor area 
were recorded during 342 s irradiation. The maximum temperature change could 
reach to 12 K. By comparison, when only irradiation was implemented, the tumor’s 
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temperature changed barely (Figure S15). Many literatures indicated the desired 
effective temperature of thermal therapy located around 43-45 oC44-47, therefore, it 
was increasingly necessary to monitor the real-time variation during this temperature 
range. As shown in Figure 4A, the real-time and accurate temperature change ranging 
between 6 and 10 degrees was recorded. In addition, the time resolution was as high 
as 19 seconds per frame, which ensured the parameters (illumination intensity and 
time, etc.) of PTT could be adjusted in time, thus leading to tremendous improvement 
of accuracy for PTT. It was feasible and satisfactory to dynamically observe the tumor 
temperature variation in different ROIs utilizing MRTI. As described in Figure 4B-C, 
the temperature of different ROIs in tumor increased along with irradiation time, 
which contributed to monitoring the treatment of tumor in time.  
In addition, it was of great significance to record the real-time temperature change 
in tumor and adjacent normal tissue, which was favorable to maximize thermal 
ablation of tumor and minimize damage to healthy tissue. The temperature change 
was investigated in three different ROIs (Figure 5), including ROI (1) in tumor, ROI 
(2) and ROI (3) in peritumor normal tissue. Compared to ROI (2) and ROI (3), the 
temperature of ROI (1) increased significantly, which meant this strategy was capable 
of improving PTT therapeutic effect and reducing thermal radiation damage to normal 
tissues. The temperature resolution between adjacent time intervals could be as low as 
0.1 K, ensuring the accuracy of temperature change. As a result, on a single MRI 
machine, dual-modality MRI (T1/MRTI) could be adopted to localize PTAs and 
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monitor the real-time temperature change during PTT to improve the accuracy of 
PTT. 
Monitoring temperature without soft tissue depth limitation by MRTI 
The capability of temperature monitoring between infrared thermal camera and 
magnetic resonance imaging was next compared. The association between 
temperature and depth in vivo by MRTI was firstly studied. From Figure S16, 
temperature change in vivo at different depths (0-12 mm) was measured accurately. 
Comparatively, infrared thermal camera was used to imitatively record the 
temperature change in various depths. As shown in Figure S17, infrared thermal 
camera was utilized to measure the temperature change of NaBiF4: Gd@PDA@PEG 
solution covered with different thickness (0, 0.25, 0.5, 1.0, 2.0, 3.0 cm) of pork during 
irradiation. Without pork tissue, camera had the ability to real-time record the 
temperature fluctuation. However, infrared thermal camera couldn’t accurately reflect 
the temperature change even with the thinnest pork thickness (2.5 mm). In a word, 
MRTI could be qualified for monitoring the real-time temperature change in vivo with 
little soft tissue depth limitation compared to infrared thermal camera.   
Toxicity and biocompatibility of NaBiF4: Gd@PDA@PEG nanoparticles in vivo 
In consideration of clinical application of NaBiF4: Gd@PDA@PEG, its toxicity and 
biocompatibility in vivo were investigated. 100 μL of NaBiF4: Gd@PDA@PEG 
(10000 ppm, Bi) solution or PBS (control group) was intravenously into healthy mice 
for short-term (3 days) and long-term (30 days) potential toxicity consideration. After 
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a month's careful examination, there was no significant difference in body weight 
between the experimental group and the control group (Figure S18). Moreover, 
hematoxylin and eosin (H&E) results also demonstrated the safety of heart, liver, 
spleen, lung and kidney (Figure S19). The tests of serum biochemistry and 
hematology further validated the outstanding biocompatibility and low toxicity of 
NaBiF4: Gd@PDA@PEG (Figure S20). Then, the mice digital images were acquired 
to indicate the photothermal capability of NaBiF4: Gd@PDA@PEG to kill tumor after 
PTT (Figure S21). H&E staining of tumor demonstrated large areas of necrosis 
appeared after photothermal therapy (Figure S22). In addition, the pharmacokinetic 
property of NaBiF4: Gd@PDA@PEG was reflected by its half-life of blood (t0.5) of 
mice (Figure S23), which was calculated as 76 min. And its biodistribution revealed 
the nanomaterials were mainly accumulated in the liver and spleen (Figure S24).  
In conclusion, an innovative strategy was proposed to integrate T1-MRI with MRTI 
for efficiently evaluating the spatial location of nanoPTAs, and accurately monitoring 
the real-time temperature change in vivo during PTT on a single MRI machine. The 
strategy could reveal the spatial temperature change with high accuracy, and further 
ensure the effective ablation of tumor with minimal damage to normal tissue. We 
demonstrated that NaBiF4: Gd@PDA@PEG as nanoPTAs had favorable 
biocompatibility. T1-weighted properties (the longitudinal relaxation rate (r1) of 1.2 
mM-1 s-1) on an 11.7 T ultra-high field MRI machine made it possible to locate the 
distribution of nanoPTAs accurately, further giving detailed structural information of 
tumor. In addition, excellent photothermal conversion performance enabled NaBiF4: 
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Gd@PDA@PEG nanomaterials to be highly effective in eradicating tumors. 
Simultaneously, NaBiF4: Gd@PDA@PEG had exceedingly weak susceptibility 
(1.04*10-6 emu g-1 Oe-1) and little interference to local phase. Therefore, MRTI had 
the capability to dynamically record real-time temperature change in tumor and 
adjacent normal tissue. The time resolution could reach to 19 seconds per frame and 
the detection accuracy of temperature change was about 0.1 K. On a single machine, 
integrating anatomic with functional MRI for guiding PTT was of great significance 
to eliminate thermal damage to normal tissue and improve PTT accuracy, which 













Scheme 1. Scheme of integrated MRI for guiding photothermal therapy. NanoPTAs 
with outstanding photothermal conversion performance and T1-weighted capability 
were synthesized. On a single 11.7 T magnetic machine, anatomic MRI (T1-MRI) 
was utilized to track nanoPTAs and exhibit more detailed structure information in 
tumor, meanwhile, functional MRI (MRTI) was conducted to accurately record the 









Figure 1. TEM images of NaBiF4: Gd@PDA@PEG (A); High-angle annular dark 
field image of NaBiF4: Gd@PDA@PEG (B); The element mapping (Na, Bi, F, Gd, C, 
O) images of NaBiF4: Gd@PDA@PEG (C). Scale bars were 200 nm. The XPS 
spectra of NaBiF4: Gd@PDA@PEG (D), Gd 3d: 1186.8 (E), Na 1s: 1071.2 (F), F 1s: 




Figure 2. T1 weighted gray images and T1 mapping images of NaBiF4: 
Gd@PDA@PEG nanoparticles in different concentration of Gd (A); the responding 
longitudinal relaxtion (R1) against the concentration of Gd (B); Hysteresis loops of 
NaBiF4: Gd@PDA@PEG nanoparticles at 300 K of temperature and 3 T of magnetic 
intensity (C); Phase changed along with temperature in agar with NaBiF4: 
Gd@PDA@PEG of different Gd concentration (0, 30, 60 ppm). Blue line (Gd, 0 






Figure 3. T1 weighted MRI images before (A, gray; C, pseudo color) and after (B, 
gray; D, pseudo color) intratumor injection of NaBiF4: Gd@PDA@PEG (Gd, 61.5 
ppm, Bi, 800 ppm, 100 μL). Real-time temperature monitoring of tumors during 342 s 
of photothermal therapy after intratumor injection of NaBiF4: Gd@PDA@PEG. Time 
interval was 57 s, the 2-D (E) and 3-D (F) temperature mapping images were 
acquired. The area of dashed line was tumor and that of arrow was T1 signal 




Figure 4. Real-time temperature monitoring of tumors of PTT after intratumor 
injection at time interval of 20 s, and the 2-D and 3-D temperature mapping images 










Figure 5. T1 images after intratumor injection of NaBiF4: Gd@PDA@PEG (A). And 
the temperature change in three ROI was acquired and compared during PTT. 1: 
tumor; 2 and 3: normal tissue near tumor. The corresponding temperature variation in 
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